Synmosa Biopharma Corporation (TPEX:4114)
Taiwan
· Delayed Price · Currency is TWD 30.90
0.00 (0.00%)
Apr 29, 2026, 1:30 PM CST
Synmosa Biopharma Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 1,891 | 1,186 | 918.56 | 1,088 | 868.17 | Upgrade
|
| Short-Term Investments | 318.15 | 120.31 | 520 | 310 | 115 | Upgrade
|
| Trading Asset Securities | 721.96 | 575.94 | 211.45 | 20.1 | 5.26 | Upgrade
|
| Cash & Short-Term Investments | 2,931 | 1,882 | 1,650 | 1,418 | 988.43 | Upgrade
|
| Cash Growth | 55.73% | 14.08% | 16.38% | 43.43% | 32.61% | Upgrade
|
| Accounts Receivable | 1,382 | 1,252 | 1,155 | 1,125 | 799.64 | Upgrade
|
| Other Receivables | 62.32 | 57.88 | 48.43 | 20.86 | 10.47 | Upgrade
|
| Receivables | 1,444 | 1,310 | 1,203 | 1,146 | 810.11 | Upgrade
|
| Inventory | 2,247 | 1,787 | 1,651 | 1,384 | 1,214 | Upgrade
|
| Prepaid Expenses | 43.82 | 34.54 | 28.1 | - | 51.11 | Upgrade
|
| Other Current Assets | 1.87 | 5.31 | 7 | 60.84 | 35.05 | Upgrade
|
| Total Current Assets | 6,669 | 5,019 | 4,539 | 4,008 | 3,099 | Upgrade
|
| Property, Plant & Equipment | 5,425 | 5,589 | 5,557 | 5,638 | 5,662 | Upgrade
|
| Long-Term Investments | 387.28 | 336.48 | 222.87 | 223.01 | 303.48 | Upgrade
|
| Goodwill | 50.26 | 62.29 | 62.29 | 71.08 | 7.27 | Upgrade
|
| Other Intangible Assets | 383.9 | 449.22 | 496.56 | 496.8 | 494.03 | Upgrade
|
| Long-Term Deferred Tax Assets | 399.47 | 363.27 | 330.56 | 331.78 | 329.28 | Upgrade
|
| Other Long-Term Assets | 671.08 | 484.54 | 519.9 | 433.53 | 421.53 | Upgrade
|
| Total Assets | 13,985 | 12,304 | 11,729 | 11,203 | 10,317 | Upgrade
|
| Accounts Payable | 561.2 | 471.02 | 427.54 | 446.16 | 249.58 | Upgrade
|
| Accrued Expenses | 496.44 | 443.36 | 381.68 | 368.47 | 264.64 | Upgrade
|
| Short-Term Debt | 686.48 | 674.89 | 661.22 | 584.08 | 763.77 | Upgrade
|
| Current Portion of Long-Term Debt | 230.4 | 72.33 | 289.39 | 584.42 | 413.9 | Upgrade
|
| Current Portion of Leases | 25.57 | 22.94 | 23.3 | 16.7 | 6.74 | Upgrade
|
| Current Income Taxes Payable | 119.75 | 142.57 | 118.29 | 95.54 | 53.18 | Upgrade
|
| Current Unearned Revenue | 86.41 | 163.72 | 172.29 | 173.43 | 126.87 | Upgrade
|
| Other Current Liabilities | 56.06 | 83.76 | 44.71 | 53.91 | 10.21 | Upgrade
|
| Total Current Liabilities | 2,262 | 2,075 | 2,118 | 2,323 | 1,889 | Upgrade
|
| Long-Term Debt | 1,537 | 1,729 | 1,400 | 2,122 | 2,272 | Upgrade
|
| Long-Term Leases | 33.67 | 49.86 | 58.66 | 48.42 | 6.76 | Upgrade
|
| Long-Term Unearned Revenue | 8.84 | 5.53 | 2.35 | - | - | Upgrade
|
| Pension & Post-Retirement Benefits | 7.48 | 7.8 | 12.24 | 13.89 | 19.18 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 35.59 | 37.42 | 35.45 | 34.52 | 34.2 | Upgrade
|
| Other Long-Term Liabilities | 1.06 | 1.26 | 0.53 | 12.62 | 0.89 | Upgrade
|
| Total Liabilities | 3,886 | 3,905 | 3,628 | 4,554 | 4,221 | Upgrade
|
| Common Stock | 5,102 | 4,293 | 4,014 | 3,437 | 3,131 | Upgrade
|
| Additional Paid-In Capital | 2,627 | 2,082 | 2,195 | 1,425 | 1,426 | Upgrade
|
| Retained Earnings | 1,279 | 1,096 | 1,092 | 1,005 | 613.43 | Upgrade
|
| Treasury Stock | -154.04 | -205.68 | -486.96 | -486.96 | -402.62 | Upgrade
|
| Comprehensive Income & Other | -89.1 | -55.82 | -104.78 | -68.18 | -63.04 | Upgrade
|
| Total Common Equity | 8,764 | 7,210 | 6,710 | 5,312 | 4,706 | Upgrade
|
| Minority Interest | 1,335 | 1,189 | 1,391 | 1,337 | 1,390 | Upgrade
|
| Shareholders' Equity | 10,099 | 8,399 | 8,101 | 6,649 | 6,095 | Upgrade
|
| Total Liabilities & Equity | 13,985 | 12,304 | 11,729 | 11,203 | 10,317 | Upgrade
|
| Total Debt | 2,513 | 2,549 | 2,433 | 3,355 | 3,463 | Upgrade
|
| Net Cash (Debt) | 418.19 | -666.47 | -782.59 | -1,937 | -2,474 | Upgrade
|
| Net Cash Per Share | 0.84 | -1.44 | -1.75 | -4.49 | -5.69 | Upgrade
|
| Filing Date Shares Outstanding | 502.77 | 462.21 | 462.21 | 429.15 | 432.91 | Upgrade
|
| Total Common Shares Outstanding | 502.77 | 462.21 | 462.21 | 429.15 | 432.91 | Upgrade
|
| Working Capital | 4,406 | 2,945 | 2,421 | 1,686 | 1,210 | Upgrade
|
| Book Value Per Share | 17.43 | 15.60 | 14.52 | 12.38 | 10.87 | Upgrade
|
| Tangible Book Value | 8,330 | 6,699 | 6,151 | 4,744 | 4,204 | Upgrade
|
| Tangible Book Value Per Share | 16.57 | 14.49 | 13.31 | 11.05 | 9.71 | Upgrade
|
| Land | 3,392 | 3,528 | 3,528 | 3,558 | 3,558 | Upgrade
|
| Buildings | 1,619 | 1,587 | 1,567 | 1,558 | 1,542 | Upgrade
|
| Machinery | 2,282 | 2,050 | 1,893 | 1,790 | 1,696 | Upgrade
|
| Construction In Progress | 19.41 | 89.55 | 19.08 | 9.74 | 62.51 | Upgrade
|
| Leasehold Improvements | 83.23 | 83.19 | 80.49 | 78.96 | 22.62 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.